Gilead Sciences discloses updated portfolio positions in 13F filing: Maintained RCUS GLPG ACLX ASMB KYTX holdings, Exited CYPH TNGX (151.81 -3.99)
Highlights from Q4 2025 filing as compared to Q3 2025 (all amounts are approximate):
- Maintained: RCUS (31.42 mln shares), GLPG (16.71 mln), ACLX (6.72 mln), ASMB (4.51 mln), KYTX (4.13 mln)
- Exited: CYPH (from 5.32 mln shares), TNGX (4.85 mln)